SI c.1494A>C ;(p.Q498H)

Variant ID: 3-164773000-T-G

NM_001041.3(SI):c.1494A>C;(p.Q498H)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1.

Antiviral Research
Hashizume, Mei M; Takashima, Ayako A; Ono, Chikako C; Okamoto, Toru T; Iwasaki, Masaharu M
Publication Date: 2022-12-05

Variant appearance in text: SI: Q498H
PubMed Link: 36481388
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Zhang, Wei W; Shi, Ke K; Geng, Qibin Q; Ye, Gang G; Aihara, Hideki H; Li, Fang F
Publication Date: 2022-11

Variant appearance in text: SI: Q498H
PubMed Link: 36256797
Variant Present in the following documents:
  • pnas.202206509.pdf
View BVdb publication page



Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19.

Science Bulletin
Lin, Xian X; Ke, Xianliang X; Jian, Xiaoqin X; Xia, Lin L; Yang, Yang Y; Zhang, Tianying T; Xiong, Hualong H; Zhao, Binghai B; Liu, Wen W; Chen, Quanjiao Q; Tang, Chong C
Publication Date: 2022-05-30

Variant appearance in text: SI: Q498H
PubMed Link: 35186363
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.

Cell
Hoffmann, Markus M; Krüger, Nadine N; Schulz, Sebastian S; Cossmann, Anne A; Rocha, Cheila C; Kempf, Amy A; Nehlmeier, Inga I; Graichen, Luise L; Moldenhauer, Anna-Sophie AS; Winkler, Martin S MS; Lier, Martin M; Dopfer-Jablonka, Alexandra A; Jäck, Hans-Martin HM; Behrens, Georg M N GMN; Pöhlmann, Stefan S
Publication Date: 2022-02-03

Variant appearance in text: SI: Q498H
PubMed Link: 35026151
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.

Cell
Hoffmann, Markus M; Krüger, Nadine N; Schulz, Sebastian S; Cossmann, Anne A; Rocha, Cheila C; Kempf, Amy A; Nehlmeier, Inga I; Graichen, Luise L; Moldenhauer, Anna-Sophie AS; Winkler, Martin S MS; Lier, Martin M; Dopfer-Jablonka, Alexandra A; Jäck, Hans-Martin HM; Behrens, Georg M N GMN; Pöhlmann, Stefan S
Publication Date: 2021-12-24

Variant appearance in text: SI: Q498H
PubMed Link: 35026151
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page